Trial · NCT00527111
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Chemoradiotherapy Plus Cetuximab | 5 | 67 | 6 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Chemoradiotherapy Alone | 8 | 62 | 8 |
| other | ANEMIA | Blood and lymphatic system disorders | Chemoradiotherapy Plus Cetuximab | 5 | 67 | 6 |
| other | ANEMIA | Blood and lymphatic system disorders | Chemoradiotherapy Alone | 6 | 62 | 8 |
| other | ANOREXIA | Gastrointestinal disorders | Chemoradiotherapy Plus Cetuximab | 16 | 67 | 19 |
| other | ANOREXIA | Gastrointestinal disorders | Chemoradiotherapy Alone | 13 | 62 | 15 |
| other | CHILLS | General disorders | Chemoradiotherapy Plus Cetuximab | 7 | 67 | 7 |
| other | CHILLS | General disorders | Chemoradiotherapy Alone | 1 | 62 | 1 |
| other | CONSTIPATION | Gastrointestinal disorders | Chemoradiotherapy Plus Cetuximab | 8 | 67 | 9 |
| other | CONSTIPATION | Gastrointestinal disorders | Chemoradiotherapy Alone | 5 | 62 | 5 |
| other | DEHYDRATION | Gastrointestinal disorders | Chemoradiotherapy Plus Cetuximab | 7 | 67 | 8 |
| other | DEHYDRATION | Gastrointestinal disorders | Chemoradiotherapy Alone | 8 | 62 | 13 |
| other | DIARRHEA | Gastrointestinal disorders | Chemoradiotherapy Plus Cetuximab | 36 | 67 | 67 |
| other | DIARRHEA | Gastrointestinal disorders | Chemoradiotherapy Alone | 33 | 62 | 60 |
| other | DRY SKIN | Skin and subcutaneous tissue disorders | Chemoradiotherapy Plus Cetuximab | 5 | 67 | 6 |
| other | DRY SKIN | Skin and subcutaneous tissue disorders | Chemoradiotherapy Alone | 0 | 62 | 0 |
| other | FEVER | General disorders | Chemoradiotherapy Plus Cetuximab | 6 | 67 | 6 |
| other | FEVER | General disorders | Chemoradiotherapy Alone | 0 | 62 | 0 |
| other | HAND-FOOT SYNDROME | Skin and subcutaneous tissue disorders | Chemoradiotherapy Plus Cetuximab | 2 | 67 | 4 |
| other | HAND-FOOT SYNDROME | Skin and subcutaneous tissue disorders | Chemoradiotherapy Alone | 9 | 62 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00527111/events